Literature DB >> 24184981

Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons.

B K Taylor1, W Fu2, K E Kuphal3, C-O Stiller4, M K Winter5, W Chen6, G F Corder2, J H Urban7, K E McCarson5, J C Marvizon6.   

Abstract

Neuropeptide Y (NPY) is present in the superficial laminae of the dorsal horn and inhibits spinal nociceptive processing, but the mechanisms underlying its anti-hyperalgesic actions are unclear. We hypothesized that NPY acts at neuropeptide Y1 receptors in the dorsal horn to decrease nociception by inhibiting substance P (SP) release, and that these effects are enhanced by inflammation. To evaluate SP release, we used microdialysis and neurokinin 1 receptor (NK1R) internalization in rat. NPY decreased capsaicin-evoked SP-like immunoreactivity in the microdialysate of the dorsal horn. NPY also decreased non-noxious stimulus (paw brush)-evoked NK1R internalization (as well as mechanical hyperalgesia and mechanical and cold allodynia) after intraplantar injection of carrageenan. Similarly, in rat spinal cord slices with dorsal root attached, [Leu(31), Pro(34)]-NPY inhibited dorsal root stimulus-evoked NK1R internalization. In rat dorsal root ganglion neurons, Y1 receptors colocalized extensively with calcitonin gene-related peptide (CGRP). In dorsal horn neurons, Y1 receptors were extensively expressed and this may have masked the detection of terminal co-localization with CGRP or SP. To determine whether the pain inhibitory actions of Y1 receptors are enhanced by inflammation, we administered [Leu(31), Pro(34)]-NPY after intraplantar injection of complete Freund's adjuvant (CFA) in rat. We found that [Leu(31), Pro(34)]-NPY reduced paw clamp-induced NK1R internalization in CFA rats but not uninjured controls. To determine the contribution of increased Y1 receptor-G protein coupling, we measured [(35)S]GTPγS binding simulated by [Leu(31), Pro(34)]-NPY in mouse dorsal horn. CFA inflammation increased the affinity of Y1 receptor G-protein coupling. We conclude that Y1 receptors contribute to the anti-hyperalgesic effects of NPY by mediating the inhibition of SP release, and that Y1 receptor signaling in the dorsal horn is enhanced during inflammatory nociception.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid; ANOVA; CFA; CGRP; DRG; G-protein; HEPES; IB4; NK1R; NPY; PBS; RIA; SP; SP-LI; SP-like immunoreactivity; aCSF; analysis of variance; artificial cerebrospinal fluid; calcitonin gene-related peptide; capsaicin; complete Freund’s adjuvant; dorsal root ganglion; isolectin B4; isolectin-B4; neurokinin 1 receptor; neurokinin-1 receptor; neuropeptide Y; pain; phosphate-buffered saline; radioimmunoassay; substance P

Mesh:

Substances:

Year:  2013        PMID: 24184981      PMCID: PMC4363128          DOI: 10.1016/j.neuroscience.2013.10.054

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  77 in total

1.  Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors.

Authors:  Oludare B Taiwo; Bradley K Taylor
Journal:  Pain       Date:  2002-04       Impact factor: 6.961

2.  Presynaptic regulation of spinal cord tachykinin signaling via GABA(B) but not GABA(A) receptor activation.

Authors:  R C Riley; J A Trafton; S I Chi; A I Basbaum
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

3.  Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).

Authors:  Y Dumont; A Cadieux; H Doods; A Fournier; R Quirion
Journal:  Can J Physiol Pharmacol       Date:  2000-02       Impact factor: 2.273

4.  Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor.

Authors:  P Naveilhan; H Hassani; G Lucas; K H Blakeman; J X Hao; X J Xu; Z Wiesenfeld-Hallin; P Thorén; P Ernfors
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

5.  Spinal opioid analgesia: how critical is the regulation of substance P signaling?

Authors:  J A Trafton; C Abbadie; S Marchand; P W Mantyh; A I Basbaum
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

6.  Involvement of spinal N-methyl-D-aspartate receptors in capsaicin-induced in vivo release of substance P in the rat dorsal horn.

Authors:  A W Afrah; C O Stiller; L Olgart; E Brodin; H Gustafsson
Journal:  Neurosci Lett       Date:  2001-12       Impact factor: 3.046

7.  Transmission of chronic nociception by spinal neurons expressing the substance P receptor.

Authors:  M L Nichols; B J Allen; S D Rogers; J R Ghilardi; P Honore; N M Luger; M P Finke; J Li; D A Lappi; D A Simone; P W Mantyh
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

8.  Substance P release in the spinal dorsal horn following peripheral nerve injury.

Authors:  J Wallin; E Schött
Journal:  Neuropeptides       Date:  2002-08       Impact factor: 3.286

9.  Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats.

Authors:  N A Calcutt; C Stiller; H Gustafsson; A B Malmberg
Journal:  Brain Res       Date:  2000-02-21       Impact factor: 3.252

10.  NPY Y1 receptors are present in axonal processes of DRG neurons.

Authors:  Pablo R Brumovsky; Tie Jun Shi; Hideki Matsuda; Jutta Kopp; Marcelo J Villar; Tomas Hökfelt
Journal:  Exp Neurol       Date:  2002-03       Impact factor: 5.330

View more
  15 in total

1.  Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.

Authors:  Bindu Chandrasekharan; Darra Boyer; Joshua A Owens; Alexandra A Wolfarth; Bejan J Saeedi; Tanvi Dhere; Heba Iskandar; Andrew S Neish
Journal:  Inflamm Bowel Dis       Date:  2022-03-30       Impact factor: 7.290

2.  Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.

Authors:  Juan Carlos Marvizon; Wenling Chen; Weisi Fu; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-08-02       Impact factor: 5.250

3.  Neuropeptide Y tonically inhibits an NMDAR➔AC1➔TRPA1/TRPV1 mechanism of the affective dimension of chronic neuropathic pain.

Authors:  Weisi Fu; Caitlin R Wessel; Bradley K Taylor
Journal:  Neuropeptides       Date:  2020-01-24       Impact factor: 3.286

4.  Involvement of Neuropeptide Y in Post-Incisional Nociception in Rats.

Authors:  Shivani Gupta; Mayank Gautam; Pranav Prasoon; Rahul Kumar; Subrata Basu Ray; Saroj Kaler Jhajhria
Journal:  Ann Neurosci       Date:  2018-12-04

Review 5.  The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour.

Authors:  A Farzi; F Reichmann; P Holzer
Journal:  Acta Physiol (Oxf)       Date:  2015-01-09       Impact factor: 6.311

6.  An NPY Y1 receptor antagonist unmasks latent sensitization and reveals the contribution of protein kinase A and Epac to chronic inflammatory pain.

Authors:  Weisi Fu; Tyler S Nelson; Diogo F Santos; Suzanne Doolen; Javier J P Gutierrez; Na Ye; Jia Zhou; Bradley K Taylor
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

7.  Fast A-type currents shape a rapidly adapting form of delayed short latency firing of excitatory superficial dorsal horn neurons that express the neuropeptide Y Y1 receptor.

Authors:  Ghanshyam P Sinha; Pranav Prasoon; Bret N Smith; Bradley K Taylor
Journal:  J Physiol       Date:  2021-04-18       Impact factor: 6.228

8.  Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF.

Authors:  Alexandre Henriques; Stefan Kastner; Eva Chatzikonstantinou; Claudia Pitzer; Christian Plaas; Friederike Kirsch; Oliver Wafzig; Carola Krüger; Robert Spoelgen; Jose-Luis Gonzalez De Aguilar; Norbert Gretz; Armin Schneider
Journal:  Front Cell Neurosci       Date:  2015-01-20       Impact factor: 5.505

9.  Bone Injury and Repair Trigger Central and Peripheral NPY Neuronal Pathways.

Authors:  Cecília J Alves; Inês S Alencastre; Estrela Neto; João Ribas; Sofia Ferreira; Daniel M Vasconcelos; Daniela M Sousa; Teresa Summavielle; Meriem Lamghari
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

Review 10.  Targeting spinal neuropeptide Y1 receptor-expressing interneurons to alleviate chronic pain and itch.

Authors:  Tyler S Nelson; Bradley K Taylor
Journal:  Prog Neurobiol       Date:  2020-08-07       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.